Reversal of Severe Multiorgan Failure Associated With Sickle Cell Crisis Using Plasma Exchange: A Case Series.

Gulrukh Z ZaidiJuliana A RosentsveygKatayoun F FomaniJames P LouieSeth J Koenig

Published in: Journal of intensive care medicine (2019)

Plasma exchange, in addition to RBCE, may be a novel synergistic treatment option to decrease risk of mortality in patients with refractory VOC and MOF.

Keyphrases

public health
cardiovascular events
early onset
risk factors
type diabetes
cancer therapy
cardiovascular disease
combination therapy